Myoscience Focused Cold Therapy Device Receives FDA Clearance

Myoscience in Redwood City, Calif., a medical device company, announced that the newest generation of its patented device technology has received FDA clearance for the treatment of pain.   

Advertisement

Focused Cold Therapy — the patented technology — delivers cold to targeted nerves. The cold induces a hibernating state and achieves an immediate result.

The hand-held device allows for treatment of pain without systemic side effects or addictive potential.

More Articles on Pain Management:

SPR Therapeutics Raise $5M For Commercializing Pain Therapies
Study: Joint Disorders, Back Pain Among Top Reasons People Visit Physicians
Study: Vitamin D May Not Prevent Osteoarthritis

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.